Home
About Us
Products & Services
Market Info
Market Analysis
IPO
Corporate Actions
Other Markets
Currency
Company Information
Derivative
Mutual Fund
News
Contact Us
A+
|
A
|
A-
|
Skip to Main Content
|
Home
About Us
Products & Services
Charting
Contact Us
Open Account Online
+
Trading/Demat
Mutual Fund
Board Meetings
Market
/
Corporate Action
/
Board Meetings
Easy Menu
Mutual Fund
Fund Profile
Daily Nav
Dividend Details
Scheme Profile
Historical NAV
MF News
MF Activities
Top 10 Holdings
New Fund Offer
Corporate Actions
Announcements
Book Closure
Board Meetings
Bonus Issues
Rights Issues
Delisted Shares
Market Turnover
Mergers
DeMergers
Change Of Name
Split Of Face Value
Equity
Top Gainer
Top Loser
Value
Volume
52 Weeks High / Low
Advance and Decline
New High / New Low
Live Indices
Index Movers
Beta Stockwise
Only Buyers/Sellers
Bulk Deals
Block Deals
Out / Under Performers
Index Constituents
Unusual Volume
Historical Returns
Exchange Holidays
IPO
ForthComing IPO
Open IPO
Close IPO
New Listing
New Issue Monitor
Basis Of Allotment
Best Performers
Draft Prospectus
Know IPO's/FAQ's
Other Markets
ADR Price
World Indices
Skindia GDR
Derivatives
Derivatives
Futures
Options
Easy Menu
Main Menu
About Us
Products & Services
Market
Branches
Contact Us
Open Demat Account
Market
Equity
IPO
Derivatives
Corporate Actions
Mutual Funds
Other Market
Currency
News
Market
Equity
Daily Market Trackers
Top Gainers
Announcements
|
Book Closure
|
Board Meetings
|
Bonus Issues
|
Rights Issues
|
Delisted Shares
|
Market Turnover
|
Mergers
|
DeMergers
|
Change Of Name
|
Split Of Face Value
Announcements
Book Closure
Board Meetings
Bonus Issues
Rights Issues
Delisted Shares
Market Turnover
Mergers
DeMergers
Change Of Name
Split Of Face Value
BSE Code
Company
Date
Purpose
524703
Sandu Pharma.
11-Jul-2026
Sandu Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/07/2026 inter alia to consider and approve 1. To place on record the demise of Shri Umesh B. Sandu(DIN:01132141) Managing Director of the Company on 19th June 2026 and to record the Boards appreciation for his invaluable contribution to the Company. 2. To consider and approve the appointment of a Managing Director of the Company pursuant to the demise of the erstwhile Managing Director Late Shri Umesh B. Sandu subject to the approval of the shareholders of the Company and such other statutory and regulatory approvals as may be required. 3. To consider and approve the reconstitution of the Committees of the Board. 4. To consider and approve the appointment of an Additional Director in the capacity of an Independent Director (Non-Executive) on the Board of the Company subject to the approval of the shareholders of the Company and such other statutory and regulatory approvals if any as may be required.
524723
Bijoy Hans
11-Jul-2026
Bijoy Hans Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/07/2026 inter alia to consider and approve 1. To consider & approve Acquisition of Sushodha Institute of Gastroenterology Private Limited and approval of Material Related Party Transactions with Mr. Bidari Kotresh Anilkumar. 2. To consider and evaluate a proposal for issuance of equity shares on a preferential basis for consideration other than cash (share swap). 3. To constitute Right Issue Committee of a Company. 4. To consider proposal to issue securities to the existing shareholders of the Company on Rights Basis as may be permitted under applicable law subject to such regulatory/statutory approvals as may be required. 5. To consider the approval for the postal ballot process and related actions.
530655
Goodluck India
11-Jul-2026
Goodluck India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/07/2026 ,inter alia, to consider and approve a) Issue of Bonus Equity Shares of the Company, subject to such statutory, regulatory and shareholders'' approvals as may be required. b) In principle, the proposed Corporate Restructuring of the Company, including evaluation of various restructuring options, subject to applicable laws and such approvals as may be required.
530709
Gowra Leasing
11-Jul-2026
Quarterly Results
532406
Avantel
11-Jul-2026
Avantel Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/07/2026 inter alia to consider and approve Board Meeting Intimation for Approval of Q1 Results - FY 2026-27
Prev
1
2
3
Close